...Zongtao Li; Xiaomei Gu; Junwang Tong; Bingli Liu; Liqian Sun; Xiaozeng Gao; Xiaohua Jiang Background: Knowing the status of the internal mammary lymph (IML) nodes is important for accurate staging and appropriate selection of subsequent treatment in breast cancer. We conducted a meta-analysis...

... and Methods: The study included 35 breast cancer (BC) and 15 lymphoma patients who were treated with anthracycline-based chemotherapy. Conventional echocardiography and STE were performed 1 month prior to and 1 month after chemotherapy. Longitudinal strain analysis was performed via STE using automated...

... and Methods: Data from 469 patients with axillary lymph node metastasis out of 640 early breast cancer cases were retrospectively analyzed. They were classified into 4 molecular subtypes; luminal A, luminal B HER2(+), HER2 overexpression, basal-like. LNRs were compared between groups and with other prognostic...

... of Medical Oncology (ASMO) Background: The objective of this study was to identify prognostic factors affecting the recurrence-free survival (RFS) in patients who received a 52-week trastuzumab therapy for HER2-positive early stage breast cancer (EBC). Patients and Methods: The medical records of all...

... treatment only after dissemination with that of patients who received initial adjuvant therapy. Results: After adjuvant treatment, survival in patients with disseminated breast cancer is up to a third shorter than that of patients without adjuvant therapy. Conclusions: In accordance with published evidence...

... receptor 2 (HER2)-positive breast cancer patients. Material and Methods: HER2-positive breast cancer patients without BMs who had no neurological symptoms within 12 months from diagnosis or relapse time of the disease were included in the study. The patients were distributed into 2 groups: Group 1...

...) and the clinicopathological features of breast cancer. Materials and Methods: Formalin-fixed, paraffin-embedded (FFPE) tissue samples were collected from 15 patients who had undergone surgery for primary breast cancer. The miR-21 expression levels in normal and cancer tissues were analyzed using real-time quantitative...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Ductoscopy Nipple discharge...

.... Breast reduction Mammaplasty Occult carcinoma Symmetry reconstruction Breast cancer Original Article · Originalarbeit Onkologie 2012;35:583 586 DOI: 10.1159/000342701 Published online: September 18, 2012 Pathologic Findings in Breast Reduction Specimens: Detection of Occult Premalignant...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer E-cadherin Metastatic disease Overall survival Original Article · Originalarbeit Onkologie 2012;35:414...

...Lei Yao; You-Xue Zhang; Li-Hong Wang; Xian-Yu Zhang; Wei Yan; Da Pang Background: The number of 65-year-old or older patients with breast cancer is increasing. Here we describe the clinicopathological features and prognosis of these patients. Patients and Methods: We reviewed the records of 1,651...

...Kadri Altundag; Omer Dizdar; Zeynep Ozsaran; Serdar Ozkok; Pinar Saip; Yesim Eralp; Seref Komurcu; Okan Kuzhan; Mustafa Ozguroglu; Metin Karahoca Background: The aim of this study was to determine the efficacy and safety of loading-dose intravenous (i.v.) ibandronate in women with breast cancer...

...Galia Karp; Sara Abu-Ghanem; Victor Novack; Wilmosh Mermershtain; Samuel Ariad; Netta Sion-Vardy; Etta Livneh Background: Successful treatment of breast cancer is frequently limited by the resistance of tumors to chemotherapy. Recent studies suggested a role for protein kinase C (PKC...

...Faruk Tas Background: Breast cancer (BC) is regarded as a heterogeneous disease that is classified into various molecular subtypes using gene expression analysis. The aim of this study was to perform a population-based analysis of the prevalence of molecular BC subtypes in Turkish women...

...Xiaopeng Cai; Xu Liu; Haitao Yu; Jiguang Li; Xinyu Zheng Background: Breast cancer has a high incidence worldwide, while Chinese patients have some special characteristics compared to Western patients. A meta-analysis was carried out to determine the effectiveness of breast-conserving therapy (BCT...

...Ruihua Zhao; Jiannan Wu; Weijuan Jia; Chang Gong; Fengyan Yu; Zefang Ren; Kai Chen; Jianrong He; Fengxi Su Background: Neoadjuvant chemotherapy (NAC) is increasingly being used in breast cancer treatment. Research has revealed an elevated expression of miR-221 in adriamycinresistant MCF-7/ADR cells...

...Rakesh Naidu; Yip C. Har; Nur A.M. Taib Background: The present study aimed to evaluate the association between the E-Selectin Ser128Arg polymorphism and breast cancer risk and clinicopathological characteristics of the patients. Materials and Methods: The genotypes of 387 breast cancer patients...

...Marleen Rosche; Anne-Constanze Regierer; Sandra Schwarzlose-Schwarck; Andrea Weigel; Nikola Bangemann; Jan H. Schefe; Christian W. Scholz; Kurt Possinger; Jan Eucker Background: Patients with synchronous metastastic breast cancer and intact primary tumor traditionally undergo systemic treatment...

... still pose a diagnostic dilemma in oncology practice. In this study, we evaluate if Her-2/neu mRNA expression is an alternative to FISH for detecting Her-2/neu positivity. Patients and Methods: Archival paraffin blocks of 54 breast cancer patients were analyzed for Her-2/neu status using...

...Isabell Witzel; Eva Johanna Kantelhardt; Karin Milde-Langosch; Maike Ihnen; Julia Zeitz; Nadia Harbeck; Fritz Jänicke; Volkmar Müller Background: With the more effective control of visceral metastases in patients with metastatic breast cancer (MBC), an increasing number of patients face brain...